LOGIN
Edoxaban has similar efficacy to enoxaparin for thromboprophylaxis after THA
March 2015
Edoxaban has similar efficacy to enoxaparin for thromboprophylaxis after THA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Safety and efficacy of edoxaban, an oral factor xa inhibitor, for thromboprophylaxis after total hip arthroplasty in Japan and Taiwan
J Arthroplasty. 2014 Dec;29(12):2439-46.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
264 patients scheduled for total hip arthroplasty were randomized to one of three groups: a group which received 15mg edoxaban daily, a group which received 30mg edoxaban daily, or a group which received 20mg of enoxaparin sodium twice daily. This was done to determine the safety, efficacy, and optimal dosage regimen of edoxaban as compared to enoxaparin in patients undergoing total hip arthroplas...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.